The effect of 1.25 dihydroxy vitamin D on IMT, iron indicators changes induced by inflammation and inflammatory biomarkers in patients with chronic kidney disease
Phase 2
- Conditions
- Chronic Kidney Disease.Chronic kidney disease
- Registration Number
- IRCT201211106415N3
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria:patients with chronic kidney disease; Patient's written consent to participate in the study;
CKD patients with hypovitaminosis D (serum level of 25hydroxy vitamin D<30ng/ml);
Not taking ferrous sulfate or Intravenous iron therapy;
no evidence of iron deficiencyanemia
Exclusion Crieteria:
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IMT. Timepoint: Before intervention and after intervention (2month of intervention). Method of measurement: Sonography.;Hepcidin. Timepoint: before intervention and after intervention (2month of intervention). Method of measurement: Measuring serum concentration (ng/ml).;Serum 25 hydroxy vitamin D concentration. Timepoint: Before intervention and after intervention (2month of intervention). Method of measurement: Measuring serum concentration (ng/ml).
- Secondary Outcome Measures
Name Time Method